Hypermethylation of cysteine dioxygenase 1 (CDO1) promoter is specific to IPMN and may increase with IPMN tumor progression, suggesting that CDO1 is a potential diagnostic marker of pancreatic cystic diseases (139). This evidence concerns the gene CDO1 and pancreatic intraductal papillary-mucinous neoplasm.